Instead, a similar adoptive treatment targeting MAGE-A4 and including patients with ovarian cancer has successfully been implemented [48,49,50,51], with one patient developing pseudogout arthritis [54,55]. Here, MAGEA4 is linked to ovarian carcinoma.